ArsenalBio is a clinical-stage company specializing in programmable cell therapies aimed at treating solid tumors. Focused on advancing innovative cancer therapies, the company is dedicated to defeating cancer through cutting-edge cell therapy technologies. ArsenalBio operates at the forefront of clinical development in oncology, emphasizing solid tumor treatment.

‌